-
AASLD 2024丨Dr. Jinlin Hou’s Team: Cost-Effectiveness of aMAP Score-Guided Individualized HCC Screening in HBsAg-Positive Populations
Part 1: Cirrhosis Extracellular Vesicles Secreted by Injured Hepatocytes Drive Cirrhosis-Associated Muscle Wasting Through the mtDNA-cGAS-STING Axis (Oral Presentation) • Authors: Fan Xiaoli, Peng Yunke, Li Bo • Corresponding Authors:…
-
AASLD 2024丨Dr. Jinlin Hou’s Team: Cost-Effectiveness of aMAP Score-Guided Individualized HCC Screening in HBsAg-Positive Populations
Hepatocellular carcinoma (HCC) imposes a significant health and economic burden on patients. Screening, recognized as an effective strategy to improve early diagnosis rates in high-risk populations, has garnered broad acknowledgment…
-
Combination Therapy for Advanced Gastric and Esophageal Cancers: Results from the OASIS Trial
Study Design and Participants The trial enrolled 48 participants, including 45 patients with GAC and 3 with ESCC. The therapy involved administering nivolumab 360 mg every three weeks alongside anlotinib…
-
AASLD 2024丨Dr. Qing Xie ‘s Team: Digital Precision Screening and Risk Stratification Improve Early Detection of Liver Cancer in China
Project Overview and Methods The study analyzed data from Ruijin Hospital and Lishui People’s Hospital, two participants in the “Ruiganhu” project. Between May 2023 and March 2024, a total of…
-
CCHIO 2024丨Dr. Qingbo Wang: Comprehensive Treatment Strategies for Tuberculosis-Associated Lung Cancer
At the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO), during the Infectious Tumors Subcommittee session, Dr. Qingbo Wang from The Second Hospital of Nanjing presented a report titled “Comprehensive Treatment Strategies for Tuberculosis-Associated Lung Cancer.” The presentation explored the epidemiology, diagnostic challenges, and treatment strategies for patients with coexisting tuberculosis (TB) and lung cancer.
-
CCHIO 2024丨Dr. Xiaohua Wu: Enhancing Preoperative Evaluation Strategies for Advanced Ovarian Cancer Patients
The historic city of Xi’an became a gathering place for top global oncologists as the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the Asian Oncology Socitey (AOS) took place from November 14 to 17. This event symbolized a significant integration of the global oncology community. During the gynecologic oncology session at CCHIO, Dr.…
-
CCHIO 2024丨Dr. Haitao Zhao: In the Era of Targeted Immunotherapy, Does Palliative Surgery for Responding Liver Cancer Patients
The era of targeted immunotherapy has revolutionized liver cancer treatment, offering unprecedented therapeutic efficacy. Comprehensive approaches are emerging to enhance patient outcomes, prompting a reevaluation of traditional surgical concepts for liver cancer.
-
CCHIO 2024丨Dr. Ming Zhao: Exploring Combined Local and Systemic Therapies for Intermediate and Advanced Liver Cancer—Foundations, Current Status, and Future Prospects
With advancements in local treatment techniques and the emergence of new therapeutic agents, combined local and systemic therapies have demonstrated synergistic effects greater than the sum of their parts in liver cancer management. For patients with intermediate and advanced liver cancer, this approach has improved conversion therapy success rates and even achieved curative outcomes. At…
Connecting Medical Expertise through Media